Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Mangoceuticals, Inc. (MGRX)

0.2334 -0.0209 (-8.22%)
At close: October 30 at 4:00:01 PM EDT
0.2422 +0.0088 (+3.77%)
After hours: October 30 at 7:52:10 PM EDT
Chart Range Bar
Loading chart for MGRX
  • Previous Close 0.2543
  • Open 0.2570
  • Bid 0.3053 x 200
  • Ask 0.2539 x 200
  • Day's Range 0.2291 - 0.2595
  • 52 Week Range 0.1620 - 2.4100
  • Volume 521,676
  • Avg. Volume 3,541,170
  • Market Cap (intraday) 5.187M
  • Beta (5Y Monthly) 1.98
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0200
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

www.mangoceuticals.com

3

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MGRX
68.46%
S&P 500 (^GSPC)
10.73%

1-Year Return

MGRX
88.61%
S&P 500 (^GSPC)
11.11%

3-Year Return

MGRX
97.84%
S&P 500 (^GSPC)
81.91%

5-Year Return

MGRX
99.63%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -46.97%

  • Return on Equity (ttm)

    -95.10%

  • Revenue (ttm)

    315.23k

  • Net Income Avi to Common (ttm)

    -16.28M

  • Diluted EPS (ttm)

    -1.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    228.69k

  • Total Debt/Equity (mrq)

    2.23%

  • Levered Free Cash Flow (ttm)

    1.27M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: